Alkermes Plc (ALKS)
28.15
-0.25
(-0.88%)
USD |
NASDAQ |
Mar 20, 16:00
28.23
+0.08
(+0.28%)
After-Hours: 20:00
Alkermes Research and Development Expense (Quarterly) : 91.74M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 13.23M |
| Avadel Pharmaceuticals Plc | 27.01M |
| Assertio Holdings, Inc. | 0.486M |
| Amarin Corp. Plc | 4.662M |
| Amicus Therapeutics, Inc. | 23.74M |